Mutual Fund Research

UTI Healthcare Fund-Reg(G)

As on Aug-12-2022 change fund
148.55  up-0.67 (-0.45%)

fund objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2017-20182018-20192019-20202020-20212021-2022
NAV in Rs (as on 31-Mar-2022)82.2586.1480.12139.38157.00
Net Assets(Rs Crores) (as on 31-Mar-2022) 387.31 439.81 360.08 618.13 776.23
Scheme Returns(%)(Absolute)-8.883.28-7.1376.1912.06
B'mark Returns(%)(Absolute)-14.457.46-15.0279.0813.52
Category Rank53/6232/7316/7535/7550/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2022-2023-10.89NANANA
2021-202218.403.30-0.64-7.30
2020-202130.5824.119.54-2.01
2019-2020-7.94-1.668.97-5.72
2018-20190.317.90-5.642.55
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...11.92 
Dr. Reddy's Laboratories Ltd.8.43 
Cipla Ltd.7.66 
Fortis Healthcare Ltd.4.99 
Apollo Hospitals Enterprise Ltd.4.75 
Divi's Laboratories Ltd.4.58 
Aurobindo Pharma Ltd.4.44 
Ipca Laboratories Ltd.3.92 
Ajanta Pharma Ltd.3.69 
Eris Lifesciences Ltd.3.52 

Category

Sector Funds

Launch Date

01-Aug-05

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

718.68

portfolio price to book value

5.2

investing style?

Mid Growth

fund manager?

V. Srivatsa,Kamal Gada

inception date (regular plan)

01-Aug-05

expense ratio (regular plan) %

2.60

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs79.71
Hospital & Healthcare Services16.72
Medical Equipment/Supplies/Accessories1.53

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-2005718.68-10.9823.6013.4512.9317.16
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,737.62-6.7729.05NANA20.67
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,195.58-9.0127.90NANA21.71
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20182,502.71-9.1625.76NANA17.22
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,619.53-9.8125.6918.1916.2620.06
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,667.94-8.3724.5812.6014.7614.96
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015528.65-7.7522.6615.54NA7.77
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201962.30-11.9920.62NANA16.96
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019485.08-11.4018.87NANA19.12
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021166.65NANANANA-8.08
Attention InvestorsKYC
Contact Us

Mobile No : +91 99674 32226
Tel : 22702326
Email id : assist@reliabullwealth.com

OUR OFFICE

ReliaBull Financial Services Private Limited,
No 4-D, 4th Floor, Victoria Plaza,
SV Road, Above Kora Showroom,
Santacruz West,
Mumbai – 400054

Subscribe

For all the Latest Market News, Investment Ideas.

Follow us

AMFI Registration No:88227

A Reliabull Financial Services Venture

Designed & Developed by  Accord Fintech Pvt. Ltd.